These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 498701

  • 1. Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians.
    Woolhouse NM, Andoh B, Mahgoub A, Sloan TP, Idle JR, Smith RL.
    Clin Pharmacol Ther; 1979 Nov; 26(5):584-91. PubMed ID: 498701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians.
    Woolhouse NM, Eichelbaum M, Oates NS, Idle JR, Smith RL.
    Clin Pharmacol Ther; 1985 May; 37(5):512-21. PubMed ID: 3987174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.
    Bertilsson L, Lou YQ, Du YL, Liu Y, Kuang TY, Liao XM, Wang KY, Reviriego J, Iselius L, Sjöqvist F.
    Clin Pharmacol Ther; 1992 Apr; 51(4):388-97. PubMed ID: 1345344
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa.
    Sommers DK, Moncrieff J, Avenant J.
    Hum Toxicol; 1988 May; 7(3):273-6. PubMed ID: 3391625
    [Abstract] [Full Text] [Related]

  • 8. Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings].
    Andoh B, Idle JR, Mahgoub A, Sloan TP, Smith RL, Woolhouse N.
    Br J Pharmacol; 1979 Jul; 66(3):431P. PubMed ID: 526720
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians.
    Droll K, Bruce-Mensah K, Otton SV, Gaedigk A, Sellers EM, Tyndale RF.
    Pharmacogenetics; 1998 Aug; 8(4):325-33. PubMed ID: 9731719
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.
    Dahl ML, Johansson I, Palmertz MP, Ingelman-Sundberg M, Sjöqvist F.
    Clin Pharmacol Ther; 1992 Jan; 51(1):12-7. PubMed ID: 1346258
    [Abstract] [Full Text] [Related]

  • 16. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
    Woolhouse NM, Adjepon-Yamoah KK, Mellström B, Hedman A, Bertilsson L, Sjöqvist F.
    Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
    [Abstract] [Full Text] [Related]

  • 17. Polymorphic debrisoquin hydroxylation in 757 Swedish subjects.
    Steiner E, Bertilsson L, Säwe J, Bertling I, Sjöqvist F.
    Clin Pharmacol Ther; 1988 Oct; 44(4):431-5. PubMed ID: 3168394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The debrisoquine/sparteine oxidation polymorphism: evidence of genetic heterogeneity among Ghanaians.
    Woolhouse NM.
    Prog Clin Biol Res; 1986 Oct; 214():189-206. PubMed ID: 3725761
    [No Abstract] [Full Text] [Related]

  • 20. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.
    Marandi T, Dahl ML, Kiivet RA, Rägo L, Sjöqvist F.
    Pharmacol Toxicol; 1996 May; 78(5):303-7. PubMed ID: 8737964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.